USPTO Deadlines
Next Deadline
46 days remaining
Final Refusal E-Mailed
Due Date
February 05, 2026
Extension Available
Until May 05, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 18, 2025 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Dec 18, 2025 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 18, 2025 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Dec 17, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 16, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 16, 2025 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Nov 5, 2025 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 5, 2025 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 5, 2025 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 6, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 6, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 6, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 10, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 10, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 31, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 13, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 13, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Consulting services for others in the field of design, planning, and implementation project management of clinical trials, scientific research and underrepresented community engagement
First Use Anywhere:
Jul 29, 2024
First Use in Commerce:
Aug 2, 2024
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CLINICAL TRIALS"